CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

about

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

Item

http://www.wikidata.org/entity/Q40953798

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

@en

type

Item

label

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

@en

prefLabel

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

@en

P1476

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

@en

P2093

Bing Wei

http://www.w3.org/2001/XMLSchema#string

Feng Ye

http://www.w3.org/2001/XMLSchema#string

Hong Bu

http://www.w3.org/2001/XMLSchema#string

Libo Yang

http://www.w3.org/2001/XMLSchema#string

Xiaorong Zhong

http://www.w3.org/2001/XMLSchema#string

Yan Qiu

http://www.w3.org/2001/XMLSchema#string

Zhang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Cancer invasion and the microenvironment: plasticity and reciprocity

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.

Circulating tumor cells as a window on metastasis biology in lung cancer.

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy.

P304

142-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2017.20.2.142

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28690650

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5500397

http://www.w3.org/2001/XMLSchema#string